Literature DB >> 17656498

Occupational exposure to HIV and the use of post-exposure prophylaxis.

Elizabeth Hamlyn1, Philippa Easterbrook.   

Abstract

The use of antiretroviral therapy as post-exposure prophylaxis against human immunodeficiency virus (HIV) is now routine following high-risk exposure to the HIV virus. This article summarizes the management of health care workers and others exposed to HIV in an occupational setting, and the evidence behind it.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17656498     DOI： 10.1093/occmed/kqm046

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN： 0962-7480            Impact factor:   1.611


  5 in total

1.  Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.

Authors:  Kristen Underhill
Journal:  Am J Law Med       Date:  2012

2.  Assessment of Prevalence and Determinants of Occupational Exposure to HIV Infection among Healthcare Workers in Selected Health Institutions in Debre Berhan Town, North Shoa Zone, Amhara Region, Ethiopia, 2014.

Authors:  Filmawit Aynalem Tesfay; Tesfa Dejenie Habtewold
Journal:  AIDS Res Treat       Date:  2014-11-13

3.  The DREAMS core package of interventions: A comprehensive approach to preventing HIV among adolescent girls and young women.

Authors:  Janet Saul; Gretchen Bachman; Shannon Allen; Nora F Toiv; Caroline Cooney; Ta'Adhmeeka Beamon
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

4.  Knowledge and uptake of occupational post-exposure prophylaxis amongst nurses caring for people living with HIV.

Authors:  Lufuno Makhado; Mashudu Davhana-Maselesele
Journal:  Curationis       Date:  2016-03-29

5.  Occupational exposure to blood borne pathogens among healthcare workers: a cross-sectional study of a registry in Colombia.

Authors:  Carlos Pérez-Diaz; Omar-Javier Calixto; Álvaro A Faccini-Martínez; Juan S Bravo-Ojeda; Carlos A Botero-García; Erika Uribe-Pardo; Yesid F Mantilla-Florez; Fabian Benitez; Ada Duran; Johana Osorio
Journal:  J Occup Med Toxicol       Date:  2015-12-16       Impact factor: 2.646
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.